Tencent is in line for an exit after China-based cosmetic surgery booking platform SoYoung confidentially filed to go public in the US in an offering that could raise $300m.

Nan Fung-backed mitochondrial therapy developer Stealth BioTherapeutics floated at the foot of its range to raise $78m, having disclosed $100m in financing last June.

Tencent-backed Douyu has confidentially filed to go public in the US, following another Chinese livestreaming platform, Huya, which floated last year.

Comcast and Grace Beauty-backed interactive exercise platform Peloton Interactive is interviewing banks for an offering slated for the second half of 2019.

The Taiho and Eli Lilly-backed immunotherapy developer floated in the middle of its range to raise $75.6m, valuing it at about $334m.

Nan Fung-backed biopharmaceutical company Stealth Bio has filed for an IPO that could bring in almost $87m if it floats at the top of the range.

Netmarble’s head of corporate strategy and senior vice-president, Chanseok Choi, has been promoted to managing director and head of investment.

The AbbVie, Eli Lilly, Amgen, Merck & Co and Alphabet-backed neurodegenerative disease drug developer is floating in the middle of its range.

Slack has confidentially filed for a direct listing that will allow SoftBank Vision Fund, Comcast Ventures and Alphabet unit GV to sell shares.

6 Dimensions Capital is set to exit immuno-oncology drug developer TCR² Therapeutics in an offering likely to raise between $70m and $80m.